We dedicate this paper to the memory of our friend and colleague Natalie RangelDiaz. The NMDA subtype of glutamate receptor and its co-agonist D-serine play a key role in synaptic function in the central nervous system (CNS), including visual cortex and retina. In retinal diseases such as glaucoma and macular degeneration, a loss of vision arises from malfunction of retinal cells, resulting in a glutamate hypofunctional state along the visual pathway in the affected parts of the visual field. An effective strategy to remedy this loss of function might be to increase extracellular levels of D-serine and thereby boost synaptic NMDA receptor-mediated visual transmission and/or plasticity to compensate for the impairment. We tested this idea in brain slices of visual cortex exhibiting long-term potentiation, and in rodent models of visual dysfunction caused by retinal insults at a time when the injury had stabilized to look for neuroenhancement effects. An essential aspect of the in vivo studies involved adapting sweep VEP technology to conscious rats and rabbits and combining it with intracortical recording while the animals were actively attending to visual information. Using this technology allowed us to establish complete contrast sensitivity function curves. We found that systemic D-serine dose-dependently rescued the contrast sensitivity impairment in rats with blue light-induced visual dysfunction. In rabbits with inner retinal dysfunction, both systemic and intravitreal routes of D-serine provided a rescue of visual function. In sum, we show that co-agonist stimulation of the NMDA receptor via administration of exogenous D-serine might be an effective therapeutic strategy to enhance visual performance and compensate for the loss of vision resulting from retinal disease.
Introduction
Of the D-amino acids known to exist in mammals, D-serine appears to be the most biologically active. It is present in the CNS and retina where it regulates neural communication. In higher brain regions, including the visual system, D-serine may be the dominant endogenous co-agonist for NMDA receptors that regulate glutamate-mediated neurotransmission and synaptic plasticity (Mothet et al., 2000) . This occurs at all levels of the visual axis in neurons that receive and relay afferent input from the retina to those in the lateral geniculate, superior colliculus and visual cortex. In the retina, D-serine serves as co-agonist to ganglion cell NMDA receptors that regulate light-evoked synaptic responses (Gustafson, Stevens, & Miller, 2015; Stevens et al., 2003) . Lightevoked D-serine release shapes synaptic activity in retinal ganglion cells through NMDA receptors (Daniels & Baldridge, 2010; Sullivan & Miller, 2012) and contributes to activity evoked by light stimulus onset (''ON") and offset (''OFF") (Buldyrev, Puthussery, & Taylor, 2012; Kalbaugh, Zhang, & Diamond, 2009) . NMDA receptors are known to be important for the development and refinement of the correct topographic projections from retinal ganglion cell to the superior colliculus (Shi, Aamodt, & Constantine-Paton, 1997; Simon, Prusky, O'Leary, & Constantine-Paton, 1992) , and have been implicated in transduction of visual information in the lateral geniculate and visual cortex (Hartveit & Heggelund, 1990; Scharfman, Lu, Guido, Adams, & Sherman, 1990) . NMDA receptordependent long term potentiation (LTP) occurs in many brain regions, including the visual cortex, and is viewed as a mechanism of synaptic strengthening that is fundamental to the establishment and maintenance of appropriate synaptic connections. In the hippocampus, for example, LTP has been studied as a synaptic surrogate for learning and memory (Lynch, 2003) . In the visual cortex, LTP mediates stimulus-specific response potentiation, a form of experience-dependent plasticity that contributes to visual perceptual learning in rodents (Cooke & Bear, 2010 and humans (Clapp, Hamm, Kirk, & Teyler, 2012) .
In retinal diseases such as glaucoma and macular degeneration, a loss of vision arises from degeneration or malfunction of retinal cells. Consequently, the normal neuronal transmission along the visual pathway is disrupted in the affected parts of the visual field. One strategy to remedy this loss of function would be to enhance the visual neurotransmission that remains unaffected by disease to compensate for the region of impairment. As such, lightevoked responses in retinal ganglion cells mediated by NMDA receptors are increased by D-serine (Gustafson, Stevens, Wolosker, & Miller, 2007; Sullivan & Miller, 2012) , providing a potential mechanism to improve visual function through enhancing the performance of the intact retina that remains. Alternatively, enhancing the neuronal plasticity in the adult visual system could lead to the establishment of new synaptic connections that replace the lost function and improve visual performance. In this respect, D-serine has been highlighted as a key factor that influences NMDA receptor dependent plasticity (Henneberger, Papouin, Oliet, & Rusakov, 2010) . We proposed that both of these therapeutic effects could be achieved through co-agonist stimulation of the NMDA receptor. We hypothesized that increasing extracellular D-serine levels would reverse deficient NMDA receptor function and synaptic plasticity and thereby boost visual performance to compensate for the loss of vision resulting from retinal disease.
Our approach to evaluate this idea was to first determine if added D-serine leads to an enhancement of LTP in primary visual cortex, and, if positive, test the ability of D-serine administration to restore vision in animal models of retinal disease. Visual dysfunction was caused by exposure to blue light in rats (based on a model of blue light-induced outer retinal degeneration; Wielgus et al., 2010) , and by intravitreal (IVT) NMDA injection in rabbits (NMDA model of inner retinal degeneration; Dong, Guo, Agey, Wheeler, & Hare, 2008) . Exogenous D-serine was administered systemically or directly into the eye.
Visual function was evaluated by measuring visual acuity and contrast sensitivity. Both these measures can be affected by disorders of the outer retina (e.g., macular degeneration) or by neural problems that might occur in the inner retina (e.g., glaucoma) and thereby interfere with adequate processing of visual information. The current study used sweep visual evoked potential (sweep VEP) technology, which was first introduced by Regan in 1973 and has become an important technique to assess visual acuity and contrast sensitivity in infants, young children and people with special needs (Almoqbel, Leat, & Irving, 2008; Norcia & Tyler, 1985; Norcia, Tyler, Hamer, & Wesemann, 1989; Ridder & Rouse, 2007; Tyler, Apkarian, Levi, & Nakayama, 1979) . We adapted this method of cortically recorded responses for use in conscious rats and rabbits.
Methods

Cortical slice preparation and LTP recording
All experimental procedures in this study were carried out in compliance with the guidelines on animal experimentation set forth by the Animal Care and Use Committee at Allergan and by the Association for Research in Vision and Ophthalmology (ARVO).
For LTP experiments, young adult male Sprague-Dawley rats were deeply anesthetized with isoflurane and decapitated, and the brain was rapidly removed and immersed in ice-cold artificial cerebrospinal fluid (aCSF) containing (in mM) NaCl 124, KCl 3, KH 2 -PO 4 1.25, CaCl 2 3.4, MgSO 4 2.5, NaHCO 3 26, and D-glucose 10. The area of the visual cortex was isolated by removing the frontal 2/3 portion of the brain and the cerebellum. Coronal visual cortex slices of 375 lm were prepared using a vibratome (Leica VT 1000S). The slices were maintained at 31 ± 1°C in an interface chamber continuously perfused with preheated aCSF at a rate of 1.00-1.50 ml/min, while the surface of the slices was exposed to warm, humidified 95%O 2 /5%CO 2 . Recording and stimulating began after an incubation time of at least 1 h. An extracellular recording electrode (glass micropipette filled with 2 mM NaCl) was placed in layer III, and stimulation pulses were delivered to layer IV using a bipolar-stimulating electrode (twisted nichrome wires, 65 lm).
The stimulus strength was adjusted to produce a basal field evoked post-synaptic potential (fEPSP) with an amplitude at 50% of the maximum spike-free response. Baseline stability was established for 15-30 min using single pulse stimulation at 0.05 Hz, and LTP was always induced by theta burst stimulation (TBS) consisting of 5 bursts of four pulses at 100 Hz each, separated by 200 ms and repeated two additional times at a 1 min interval. LTP was expressed as an increase in fEPSP amplitude and was monitored for at least 30 min post induction. To test the effect of D-serine on LTP, D-serine was added to the infusion line after establishing baseline stability, and LTP was initiated 15 min later. Washout of D-serine began 5 min after induction, but the magnitude of LTP continued to be monitored for another 25-30 min. Control experiments involved infusion of aCSF instead of D-serine. The concentrations of D-serine tested were as follows (in lM); 0.3 (n = 2), 1 (n = 3), 3 (n = 2), 10 (n = 4) and100 (n = 3). The magnitude of LTP was calculated as the average increase in amplitude recorded during the last 5 min of LTP (25-30 min post induction) relative to the last 5 min preceding induction. Statistical analysis was done using unpaired two-tailed t-tests comparing the average potentiation recorded in control slices to that obtained in slices treated with different concentrations of D-serine.
2.2. Preparation of rats and rabbits for long-term chronic sweep VEP recording 2.2.1. Surgical implantation of cortical VEP electrodes in rats Sweep VEP is historically used in infants (Norcia & Tyler, 1985) , but had never to our knowledge been attempted in awake rats. The key step was the use of intra-cortical electrodes, resulting in elevated VEP amplitude and improved signal to noise ratio. The animals (young adult male Long Evans rats) were fully anesthetized with isoflurane before being positioned in the stereotaxic apparatus. Depth of anesthesia was continuously monitored during surgery by a MouseOx device (Starr Life Sciences) that displays online pulse, breathing rate and blood oxygen saturation. Rectal body temperature was monitored continuously and automatically maintained at 37.8°C using a heating pad. Small holes were drilled into the skull with a dental drill (4.5 mm lateral to the midline at lambda) to allow the lowering of a recording electrode (insulated platinum wire, 75 lm diam, $500 kOhm impedance) within the binocular area of primary visual cortex in both hemispheres, using electrode holders attached to stereotaxic micromanipulators. To determine the optimal recording depth, the laminar profile of VEPs triggered by photic pulses (151 ms duration) from a Grass full field stroboscopic stimulator (1 Hz) positioned $40 cm from the contralateral eye was used as a guide, while the electrode was slowly advanced through the cortical layers until it reached layer III/IV, usually at 800-900 lm, the depth where optic tract afferents from the lateral geniculate terminate and VEPs have their maximum amplitude. At least 50 signals (band pass filtered at 0.1-300 Hz and digitized at 1000 Hz) were averaged and displayed at each step of the laminar profile. A reference and ground electrode (stainless steel jeweller screws) were placed epidurally above the frontal lobe and cerebellum, respectively. The leads of all four electrodes were inserted into a plastic connector that was permanently affixed to the skull with dental cement. Animals were allowed to recover from surgery for at least 2 weeks before experimental testing. The hemisphere maintaining the larger response was generally selected for use in subsequent sweep VEP studies.
Surgical implantation of cortical VEP electrodes in rabbits
To fully assess rabbit vision across a broad range of spatial frequencies and contrasts, the intra-cortical electrode implantation technique developed for rats described under 2.2.1 was adapted for rabbits. All subjects were young adult females of the Dutch Belted strain. They were fully anesthetized before being positioned into the rabbit stereotaxic apparatus (Kopf Instruments). Anesthesia was induced by intramuscular injection of a cocktail consisting of ketamine (35 mg/ml), xylazine (5 mg/ml) and acepromazine (0.75 mg/ml) at 0.5 ml/kg. The surgical plane was maintained by 2% isoflurane (O 2 0.8 L/min) delivered via tracheal intubation using sterile tubing (uncuffed Rusch 3.3 mm outer diameter, 2.5 mm inner diameter, lubricated with the topical anesthetic cetacaine). Intubation was necessary because the animals were in a stereotaxic unit during the surgery and an inhalation face mask would not fit. Depth of anesthesia was continuously monitored by a MouseOx device (Starr Life Sciences) that measures and displays online pulse, breathing rate and blood oxygen saturation. Rectal body temperature was monitored continuously and automatically maintained at 39°C, using a heating pad. Duration of the surgery was approximately 120 min. To place sweep VEP recording electrodes into binocular visual cortex at coordinates derived from the literature (Choudhury & Gent, 1973; Hughes & Vaney, 1982) , a small hole was drilled into the skull above the visual cortex to allow the lowering of a straight platinum wire (125 lm diam., insulated except for the blunt tip) into the retinal projection areas to primary visual cortex, i.e., layer III/IV, using electrode holders attached to stereotaxic micromanipulators. Both hemispheres were implanted to allow for within animal control comparisons. Stainless-steel jeweler screws positioned into the skull above the frontal lobe served as reference recording electrode, and a second one over the cerebellum was used as ground. Optimal recording electrode depth within visual cortex was determined by slowly advancing the electrode during photic stimulation of the contralateral retina via a Grass full field stroboscopic stimulator and using the resulting laminar profile of VEPs as a guide, until it reached layer III/IV, the depth where VEPs have their maximum amplitude. Once electrode placements had been optimized, the leads of all electrodes (including ground and reference) were inserted into a small plastic connector that was permanently affixed to the skull with dental cement. Rabbits were allowed to recover from surgery for at least 3 weeks before experimental testing.
2.3. Sweep VEP recording in rats and rabbits 2.3.1. Sweep VEP methodology
The sweep VEP recording method can provide important diagnostic information regarding the functional integrity of the visual system in humans (Norcia & Tyler, 1985; Norcia et al., 1989 ) but has been under-utilized as a technique to assess visual function in rodents due to a number of technical questions (Ridder & Nusinowitz, 2006) . The present study was facilitated by using pigmented rats and rabbits that have superior vision compared to non-pigmented strains and consequently produce a cortical signal that is sufficiently large for sweep VEP recording to reliably determine not only visual acuity, but also contrast detection thresholds across a narrow range of middle spatial frequencies, thereby providing first time elementary measures of contrast sensitivity function in the rat and rabbit.
A comprehensive review describing the fundamental properties of the sVEP technology has recently been published by Norcia and colleagues (Norcia, Appelbaum, Ales, Cottereau, & Rossion, 2015) . Grating acuity is measured by sweeping the spatial frequency of a high-contrast pattern over a wide range (spatial frequency sweep). Similarly, contrast sensitivity can be measured by varying the contrast of a fixed spatial-frequency pattern over a wide range of contrast values (contrast sweep). Measurements of contrast response and spatial frequency tuning functions using PowerDiva technology developed by Anthony Norcia (Stanford University) are illustrated in Fig. 1 and Fig. 3D & E, showing estimates of final visual acuity thresholds (in cycles of grating per degree of visual angle or cpd) and final contrast thresholds (in% contrast). The sweep VEP stimulus was a full-field, horizontally or vertically oriented sine wave grating, with a fixed temporal reversal rate and luminance. Optimal reversal frequency, luminance and vertical vs. horizontal stimulus orientation were experimentally determined for each species. Specifically, exposing the animal to a constant spatial frequency (in the mid range of the visible spectrum) and then testing different temporal frequencies allowed the selection of a reversal frequency generating maximum VEP power (lV). Similarly, establishing a luminance curve allowed the selection of an intensity needed to achieve maximum acuity (cpd) during an increasing spatial frequency sweep; i.e., acuity was highest at the selected value and did not increase further at values above, but decreased at values below. The criterion for choosing vertical vs. horizontal stimulus orientation was maximum VEP power (lV). The principal steps conducted by PowerDiva to extract threshold numbers from basic visual evoked potential sweeps can be summarized as follows. First the amplitude and phase of the evoked response at the pattern reversal rate were acquired from the raw EEG over the several seconds lasting (10-15 s) spatial frequency sweep or contrast sweep, respectively, by a Discrete Fourier Transform (DFT). The transform was then calculated over a sliding rectangular window of 1 s in duration, with each window overlapping 50% with the previous window. The EEG was processed for the amplitude of the 2nd harmonic of the modulation frequency, and an adjacent noise frequency. The signal to noise ratio was calculated by comparing the amplitude at the response frequency with the average noise amplitude. Finally, the acuity threshold was estimated as the zero microvolt intercept or linear regression on amplitude versus spatial frequency, and contrast threshold was estimated by the linear extrapolation of the VEP amplitude to zero.
Sweep VEP in conscious rats actively attending visual stimuli
Rats were wrapped tightly into a terry cloth except for their head and placed in a custom-made restraining device that provided sufficient stability for the entire body without obstructing their field of vision. The animals were habituated repeatedly across several days until they learned to sit still for at least 10 min, the time needed to conduct sufficient trials for a complete sweep VEP recording session. It was essential that the animal remained alert and paid attention during stimulus presentation. The rat was aligned with the stimulus monitor such that the display was centered at the vertical meridian of the eye at a viewing distance of 24 cm and the binocular visual field was stimulated. The opposite eye was obstructed by a black patch. PowerDiva technology (see Section 2.3.1 above) was used for stimulus production, data acquisition and analysis including estimation of visual acuity and contrast thresholds. The sweep VEP stimulus was a full-field, horizontally oriented sine wave grating with a temporal reversal rate of 6.25 Hz. Mean luminance was held constant at 20 candelas (cd). To determine visual acuity thresholds, the sweep consisted of 15 spatial frequencies increasing from 0.3 to 1.8 cpd in 15 linear steps at 80% contrast. Each spatial frequency was presented for 1 s, so that the entire sweep took 16 s (15 spatial frequencies plus 1 s pre-adaptation). To determine contrast thresholds, a trial consisted of a contrast sweep increasing from 2.5% to 70% in 15 logarithmic steps, with the spatial frequency kept constant at pre-determined values, typically either at 0.5, 0.575 or 0.65 cpd. Each contrast setting was presented for 1 s, so that the entire sweep took 16 s (15 contrast values plus 1 s pre-adaptation). Contrast sensitivity was calculated as the inverse of the contrast threshold. The sweeps were averaged until the signal to noise ratio was at least 3 or above. According to the principles of the DFT technique, which was employed to determine the amplitude of the second harmonic of the sweep VEP responses, at a signal to noise ratio of 3, the noise contamination of the signal is minimal (Bach & Meigen, 1999; Norcia et al., 1989) . Usually at least 9 trials and no more than 30 trials were required. The length of time an animal participated in experiments was determined by the quality of the recording that can deteriorate over time mainly due to changes in electrode impedance. Typically rats with chronic implants remained healthy and grew normally and thus kept viable recordings for more than 12 months.
Sweep VEP in conscious rabbits actively attending visual stimuli
Rabbits are commonly used for vision studies because their eyes are relatively large and their visual acuity is superior to rats. Visual acuity thresholds assessed by sweep VEP are approximately 1 cpd for Long Evans rats and 3 cpd for Dutch Belted rabbits. Rabbits also have a fairly calm disposition that is conducive to conscious sweep VEP recording. They possess a very large visual field that contains an ''area centralis" or ''visual streak" characterized by higher RGC density. The visual streak is effortlessly localized by a fundus camera that can be used to project the stimulus sweep directly onto the proper region of the retina.
Only females served as subjects because male rabbits grow too large to fit comfortably into the restrainer as they get older. A sweep VEP recording set-up, developed originally for rabbits with simple cranial screw electrodes, was used. Rabbits were placed in a custom-made restraining cage with the head at a fixed distance ($2 cm) from the lens of the fundus camera that was used to project the grating stimulus to the back of the rabbit's eye. The animals did not need much habituation and easily adapted to sitting still in the apparatus for extended time periods. A typical recording session lasted between 10 and 20 min. PowerDiva technology (see Section 2.3.1 above) was used for stimulus creation, data acquisition and final analysis that included estimates of visual acuity and contrast thresholds. The pupil of the animal was fully dilated with phenylephrine and tropicamide for a minimum of 10 min before placing the animal in the restrainer for recording to begin. The sweep VEP stimulus was a full-field, vertically oriented sine wave grating with a temporal reversal rate of 7.5 Hz. Mean lumi- Fig. 1 . Contrast sensitivity function (CSF) in rabbit measured by sweep VEP methodology. Graphic illustration of process used to construct and fit a complete rabbit CSF curve based on five strategic sweep VEP threshold measurements outlining the boundary of the rabbit's visible space. The three data points on the top left and middle part of the curve represent contrast sweep thresholds at three fixed spatial frequencies of 1.15 1.45 and 1.75 cpd (depicted by blue dotted lines, with vertical arrows indicating sweep direction). The two data points on the bottom right portion of the curve represent spatial frequency sweep thresholds, i.e., visual acuity thresholds, at two fixed contrasts of 25% and 80% (depicted by magenta dotted lines, with horizontal arrow indicating sweep direction). PowerDiva sweep VEP summary plots at the top and to the right of the curve display the actual contrast and visual acuity threshold measurements that were used to construct the CSF curve, with grey solid arrows pointing to the corresponding data point on the curve. Each PowerDiva plot represents the average of 20-30 sweeps.
nance was held constant at 40 candelas (cd). The stimulus display was projected directly into the eye using a Veris Fundus Camera (Electro Diagnostic Imaging) that was focused onto the retina at the central area just below the visual streak. To determine visual acuity thresholds, the sweep consisted of 10 spatial frequencies increasing from 0.1 to 5.0 cpd in 10 linear steps with the contrast kept constant throughout the session (usually at 80% or 25%). Each spatial frequency was presented for 1 s, so that the entire sweep took 11 s (10 spatial frequencies plus 1 s pre-adaptation). To determine contrast thresholds, a trial consisted of a contrast sweep increasing from 5% to 70% in 10 logarithmic steps, with the spatial frequency kept constant at pre-determined values, typically at 1.15, 1.45, 1.6 or 1.75 cpd). Each contrast setting was presented for 1 s, so that the entire sweep took 11 s (10 contrast values plus 1 s pre-adaptation). For both visual acuity and contrast threshold determination, the sweeps were averaged until the noise contamination of the signal became minimal, which required a signal to noise value equal to 3 or better and typically between 20 and 30 trials per session. Contrast sensitivity was calculated as the inverse of the contrast threshold. At least three contrast thresholds at lower and middle spatial frequencies and two acuity thresholds at 25% and 80% were typically necessary to construct and accurately fit a complete contrast sensitivity function (CSF) curve. Fig. 1 graphically illustrates this process and shows five strategic sweep VEP threshold measurements outlining the boundary of the rabbit's visible space that were used to construct the CSF curve.
The length of time an animal participated in experiments was determined by the quality of the recording that could deteriorate over time mainly due to changes in electrode impedance. Typically rabbits with chronic implants remained healthy and grew normally and thus maintained viable recordings for more than 12 months.
Models of outer and inner retinal dysfunction 2.4.1. The rat model of blue light-induced outer retinal damage
Blue-light treatment damages photoreceptors in the retina and has been proposed as a model of age related macular degeneration (ARMD; Wielgus et al., 2010) . Young adult Long Evans rats previously implanted with sweep VEP electrodes were used. They were dark-adapted for twenty-four hours prior to exposing them to blue light consisting of 6000-8000 lx ($460 nm) for 8 h. A subset of animals served as littermate controls and were returned to regular room light following dark adaptation. During the exposure time all animals had access to gel food (blue light) or food and water ad libitum (room light). After blue light/room light exposure, the animals were again dark adapted for 72-h. All procedures were conducted in accordance with AACUC guidelines.
The rabbit NMDA model of inner retinal degeneration
The rabbit NMDA model of inner retinal dysfunction has been previously used by others to study the effect of neuroprotective drugs on glaucoma (Dong et al., 2008) . It is produced by intravitreal injection of NMDA and has no detrimental effects to the overall health of the animal, but causes a dose-dependent selective loss of retinal ganglion and amacrine cells. A single injection of 3.6 lmol NMDA was found to produce the most reliable and consistent cell loss, i.e., approximately 40% of neurons in the ganglion cell layer were missing at 2 weeks after injection (Dong et al., 2008) , but its impact on functional vision had not been studied thoroughly. Our objective was to establish a long lasting and stable retinal model of contrast sensitivity dysfunction in rabbits by combining IVT NMDA injections with sweep VEP technology to quantify the extent and persistence of any vision loss. A 72 mM NMDA stock solution (pH 7.2) was made using phosphate buffered saline (PBS) and filtered with a 0.2 lm HT Tuffryn membrane. Since the rabbit vitreous volume is known to be about 1.2 ml, an injection of 50 ll stock solution (3.6 lmol NMDA) was estimated to produce a final vitreal NMDA concentration of 3 mM (1-24 dilution). The injection itself typically took less than 5 min. The animals were placed into the sweep VEP restrainer 5 min after applying a topical anesthetic (tetracaine hydrochloride 0.5%) to the ocular surface of both eyes. Conjunctiva, lids, lashes were disinfected with 5-10% povidone iodine. Using a sterile 30 gauge needle, the NMDA solution was injected into the mid vitreous cavity 4 mm behind the limbus at the superior-temporal region of the sclera. The drug was injected using a single continuous maneuver, and the needle was removed simultaneously with the application of a cotton tip pledger over the entire site. Topical (Sulfates/Bacitracin Zinc Ointment) antibiotic was applied immediately and a day later. Assignment of NMDA injection to the right vs left eye was balanced for each cohort of rabbits treated, and the fellow eye was injected with PBS using identical procedures.
Sweep VEP study design and D-serine dosing
All sweep VEP studies testing D-serine strictly followed a randomized, double-masked cross-over protocol, where half the subjects were randomly assigned to drug treatment and the other half to vehicle treatment in a first phase, followed by drug washout and a second phase with reversed assignments. An essential aspect of this study design entailed that drug treatment took place many weeks after retinal injury, at a time when the lesion had stabilized, which allowed us to look for neuroenhancement as opposed to neuroprotection effects. Since restoration of vision by acute single dosing is typically transient, using a paradigm of stable dysfunction had the advantage that each animal was tested with both drug and vehicle in a cross-over design and thus served as its own control. All data remained masked until final analysis completion.
Administration of exogenous D-serine was done by intraperitoneal (ip) injection in rats, and by subcutaneous (sc) or single intravitreal (IVT) injection in rabbits. D-serine was purchased as powder from SIGMA and dissolved in saline for systemic dosing. For intraocular delivery, D-serine was dissolved in saline and delivered as a single ll IVT injection of 12 lmol D-serine to produce an estimated final vitreal concentration of 10 mM. Equi-osmotic sucrose was used as a control.
Statistical methods
Sweep VEP studies comprising D-serine treatment were analyzed using a mixed model repeated measure (MMRM) approach, a modern multiway analysis of variance (ANOVA) that takes into account the correlations of the repeated measurements of the same subjects for the analyses of the crossover designs and that includes F-tests with Bonferroni corrected p-values for individual comparisons . Unpaired Student's t-tests were used to evaluate the long-term effect of blue light on final contrast sensitivity in rats (Fig. 3B) . . Temporary exposure to blue light produces a delayed but enduring reduction in contrast sensitivity of pigmented rats. All data were obtained using sweep VEP methodology in awake Long Evans rats. A, Time course showing mean (±s.e.m.) visual acuity thresholds after blue light exposure (n = 12) compared to untreated littermate controls (n = 6). B, Time course showing mean (±s.e.m.) contrast sensitivity values measured repeatedly during 28 weeks after blue light exposure (n = 12) compared to untreated littermate controls (n = 6). All contrast sweeps were conducted at a single spatial frequency fixed at 0.575 cpd. *** p < 0.001, Student's unpaired t-test C, Mean contrast sensitivities (±s.e.m.) at three spatial frequencies (0.5, 0.575, 0.65 cpd) measured eighteen weeks after blue light exposure in a group of twelve rats compared to six untreated littermate controls. D, Example of a Power Diva sweep VEP summary plot (Norcia et al., 1989) showing final visual acuity threshold measurements of 1.16 cpd in a control rat. The solid line (blue) in the upper panel is the response amplitude at the 2nd harmonic plotted against spatial frequency (0.3-1.8 cpd) and represents the average of 12 sweeps. Acuity threshold was estimated as the zero microvolt intercept or linear regression on amplitude versus spatial frequency (straight line, magenta). The signal to noise ratio (SNR) was calculated by comparing the amplitude at the response frequency with the average noise amplitude. The circles represent the noise. Phase is plotted from Àp to +p on the ordinate in the lower panel. E, Example of a Power Diva sweep VEP summary plot from showing final contrast threshold measurements of 13.87% in a control rat (frequency fixed at 0.65 cpd). The solid line (blue) in the upper panel is the response amplitude at the 2nd harmonic plotted against contrast (log steps from 2.5% to 70%) and represents the average of 18 sweeps at a single fixed spatial frequency. Contrast threshold was estimated by the linear extrapolation of the VEP amplitude to zero (magenta line).
Results
D-Serine enhances LTP in primary visual cortex of adult rats
Similar to earlier studies of visual cortex LTP (e.g., Kirkwood & Bear, 1994) , TBS delivered to layer IV elicited a reliable and lasting potentiation of synaptic responses in layer III of adult visual cortex. The average potentiation in untreated slices was 127 ± 3% (n = 22). The amplitude rather than the slope of the evoked fEPSP was used as a measure for synaptic potentiation, because pure dendritic field potentials cannot be isolated in this multi-laminar structure. Fig. 2B shows representative fEPSP examples recorded before and 30 min after TBS in a visual cortex slice with electrodes positioned as depicted (Fig. 2C) . The amplitude increased gradually over 3-5 min after TBS before reaching a stable potentiated level that was typically 25-35% above baseline. Analogous to LTP in the hippocampal area CA1 induced by TBS of the Schaffer collaterals, LTP induced in layer III of visual cortex by layer IV stimulation is input specific and blocked by NMDA receptor antagonists (Kirkwood & Bear, 1994) . The graph in Fig. 2A ) of contrast sensitivity at 0.575 cpd for 25 rats treated with D-serine (600 mg/kg) or saline, with a baseline taken prior to treatment (''pre") and the contrast sensitivity measured 30 min after treatment (''post"). All testing followed a randomized, double-blind cross-over protocol, where each animal was tested with both drug and vehicle, and all data remained masked until full completion of analysis. The diamond on the right of the 600 mg/kg bar indicates the score of the intact naïve group. B, Repetition of study described under A, using a different cohort of rats (n = 11) and a lower dose of D-serine (100 mg/kg). C, Example of PowerDiva contrast threshold measurements in a representative contrast sensitivity impaired rat (rat FF9) collected immediately before and 30 min after D-serine treatment (600 mg/kg), illustrating the improvement produced by D-serine. Both plots represent the average of 20-30 contrast sweeps at a fixed spatial frequency of 0.575 cpd. ) of contrast sensitivity for eight rabbits treated with D-serine or saline, with a baseline taken prior to treatment (''pre") and contrast sensitivity measured again at 90 min, 4 h and 24 h after treatment. All testing followed a randomized, doublemasked cross-over protocol, where each animal was treated with both drug and vehicle; all data remained masked until full completion of analysis. The change in contrast sensitivity from baseline to 4 h was several fold larger following D-serine than saline treatment, but the difference was not statistically significant. B, Same rabbits and study as described under A, showing mean values (±s.e.m.) of visual acuity thresholds that remained unhanged after treatment with D-serine or saline.
Differential effects of blue light exposure on visual acuity vs. contrast sensitivity in pigmented rats
In albino rats, exposure to intense blue light typically causes severe retinal damage that results in visual dysfunction (Wielgus et al., 2010) , but much less is known about blue light's effectiveness in pigmented strains. To establish the magnitude and time course of any potential visual dysfunction in Long Evans rats, visual acuity and contrast thresholds were monitored at regular intervals following intense blue light treatment and compared to values from litter mate controls exposed to room light. Remarkably, blue light treatment, identical in duration and intensity to that which typically causes immediate and severe visual dysfunction in albino rats, failed to affect standard visual acuity (measured at 80% contrast) in pigmented rats who maintained thresholds undistinguishable from those of litter mate controls for months thereafter. Fig. 3A depicts representative acuity thresholds assessed over many weeks for the first cohort of blue light treated animals and litter mate controls, showing no obvious difference between the two groups at any point. A standard plot illustrating final visual acuity threshold measurements based on PowerDiva sweep VEP methodology is shown and explained in Fig. 3D . However, blue light exposure did produce a slowly progressing impairment in contrast sensitivity that was first detectable by 4 weeks and Fig. 6 . Intravitreal NMDA administration produces a stable and long lasting reduction in contrast sensitivity function. A, Mean CSF curves for six rabbits injected with NMDA in one eye, with a baseline (average over 4 days) prior to treatment, and CSF measured again at 2 weeks and 7 months after treatment. Data points with statistically significant reductions in contrast sensitivity at 7 months compared to pre-NMDA baseline are marked with stars ( *** p < 0.003, ** p < 0.02, all with Bonferroni corrections). B, Mean CSF curves for the fellow eye of the same six rabbits but injected with PBS, with a baseline (average over 4 days) taken prior to treatment and contrast sensitivity measured again at 2 and 14 weeks after treatment. , showing an almost complete recovery of contrast sensitivity from post NMDA baseline (BL) to pre-NMDA values. B, Same rabbits and NMDA eyes as described under A, showing no response to PBS treatment (all testing followed a randomized, double-blind cross-over protocol, where the NMDA eye of each animal was treated with both D-serine and PBS). The insert above compares CSF performance before inner retinal dysfunction (pre-NMDA) to that following PBS treatment (D5 90 min), confirming the latter to be identical to post-NMDA baseline BL).
stabilized by 10 weeks after treatment (Fig. 3B) . Fig. 3C compares final contrast sensitivity values at three spatial frequencies (0.5, 0.575, 0.65 cpd) collected in rats eighteen weeks after blue-light treatment (n = 12) to those from littermate control rats (n = 6). The data were collected at spatial frequencies located in the mid range of the CSF curve for rats. A standard plot illustrating final contrast threshold measurements acquired with PowerDiva methodology is shown and explained in Fig. 3E . This pattern of intact visual acuity combined with a progressive loss in contrast sensitivity was observed in the majority of animals of all three cohorts of Long Evans rats that were exposed to blue light (n = 45).
A fraction (9/45) of Long Evans rats remained unaffected by blue light and maintained normal acuity and contrast thresholds for as long as they were monitored following blue light exposure. Specifically, of the initial two cohorts treated with blue light, only 2 from a total of 27 animals remained unaffected, but of the third cohort (treated more than one year later) seven from a total of 18 blue-light exposed rats remained unaffected. In Sprague Dawley rats, blue light treatment typically produces severe outer retinal degeneration that is manifested by well-defined changes in fundus autofluorescence appearing within 24-48 h after treatment (unpublished data). In contrast, in vivo fundus imaging of blue light exposed, contrast sensitivity impaired, Long Evans rats using a confocal scanning laser ophthalmoscope HRA (Heidelberg Retina Angiograph) failed to show any differences between treated and control retinas at any time point, implying that any structural impairment in pigmented rats might be too subtle for detection by this method.
Systemic D-Serine acutely rescues contrast sensitivity loss in rats with retinal dysfunction
As described above, contrast sensitivity, an important measure of visual performance, was significantly impaired in Long Evans rats as a result of blue light administered many weeks earlier. To investigate the potential therapeutic effects of systemic D-serine administration on this visual deficiency, 25 animals were selected based on the quality of their sweep VEP signals at a time when the visual deficit was stable, minimally 16 weeks after blue light treatment. Contrast sensitivity was assessed at 0.575 cpd, the spatial frequency with the largest impairment after blue light (see Fig. 3C ).
D-Serine was administered at 600 mg/kg ip, a dose reported to be effective in animal models of schizophrenia (Lipina, Labrie, Weiner, & Roder, 2005) and ocular dominance plasticity (Yang et al., 2011) . Half of the rats were first treated with D-serine and the other half with vehicle (saline), and reversed assignments took place one week later, allowing for each animal to serve as its own control (masked crossover study). A lower dose of D-serine (100 mg/kg) was tested in a follow-up experiment in a different cohort of rats (n = 11). Separate MMRM ANOVAs were used to analyze the results of the two doses. For 600 mg/kg, the overall treatment by time interaction was highly significant (F (1,72) = 17.92; p < 0.0001). 30 min after dosing (''post"; see Fig. 4A ), the treatment effect (difference between D-serine and saline) was highly significant with F (1,72) = 31.11, p < 0.0001 with Bonferroni correction. For D-serine, the time effect (post vs. pre) was similarly highly significant with F (1,72) = 24.72; p < 0.0001 with Bonferroni correction. It is noteworthy that D-serine at 600 mg/kg restored the blue-light induced deficit close to contrast sensitivity values found in naïve animals never exposed to blue light (10.1 ± 2.0 for naïve (n = 6) and 8.7 ± 0.6 for D-serine treated rats (n = 25). For 100 mg/kg (see Fig. 4B ), the overall treatment by time interaction was not significant (F (1,30) = 0.78, p = 0.38470. In sum, systemic D-serine administration dose-dependently ameliorated visual function deficits induced by exposure of the retina to blue light in pigmented rats. Fig. 4C illustrates the restorative effect of D-serine by showing before and after measurements of final contrast thresholds acquired with PowerDiva methodology in one representative rat.
A single IVT administration of D-serine does not significantly change contrast sensitivity in normal rabbits
Rabbits have the advantage that compounds can easily be applied intravitreally in close proximity to the retina. Our first Fig. 8 . Intravitreal D-serine acutely repairs contrast sensitivity at 1.15 cpd in rabbits with stable inner retinal dysfunction. Average contrast sensitivities at two spatial frequencies (1.15 cpd and 1.45 cpd) and acuity values at 80% contrast for fourteen rabbits treated with intravitreal D-serine (top panel) or saline (bottom panel), with a baseline taken prior to treatment (BL) and visual performance measured again at 90 min, 4 h, 24 and 48 h after treatment. D-Serine produced a significant improvement in contrast sensitivity selectively at 1.15 cpd that was restricted to 4 h post treatment. Vehicle administration had no effect on contrast sensitivity or visual acuity. study was carried out in subjects with intact vision, even though pharmacological enhancement might be more readily obtained in a dysfunctional system. To maximize the chances of observing an effect, a relatively high dose of D-serine was chosen for IVT application (a single 50 ll intravitreal injection of 12 lmol of D-serine was used to produce an estimated final vitreal concentration of 10 mM). LTP in visual cortex was strongly enhanced at 100 lM (see Fig. 2) , and a plasma concentration of 300 lM to 500 lM is known to improve neural dysfunction in patients with schizophrenia (Kantrowitz et al., 2010) , but no pharmacokinetic data was available for intravitreal D-serine. The concentration of 10 mM was targeted in the vitreous assuming that there is a steep concentration gradient between the vitreous and extracellular compartment of the neural retina. The retina contains uptake systems (O'Brien, Miller, & Bowser, 2005) , and a metabolizing enzyme (Gustafson et al., 2013) for D-serine that would reduce extracellular concentrations of exogenous D-serine within retinal tissue.
Eight animals, all previously implanted with sweep VEP electrodes, were selected based on VEP size and test-retest stability of their contrast and acuity thresholds (see Section 3.5 for detailed selection criteria description). Contrast sensitivity was assessed at 1.6 cpd, a spatial frequency in the middle range of the rabbits CSF curve (the region found sensitive to pharmacological enhancement by D-serine in the preceding rat study) and visual acuity was assessed at 80% contrast. Typically, a minimum of 5 points are required for properly fitting a complete CSF curve. The decision to selectively focus on two points brought the risk of missing a potential drug effect elsewhere on the CSF curve, but allowed for repeated post treatment sampling times, which was important considering that the T max and half life of IVT D-serine were unknown.
Half of the rabbits were first treated with IVT D-serine and the other half with IVT saline, and reversed assignments took place two weeks later, allowing for each animal to serve as its own control. Analysis with MMRM ANOVA revealed no significant overall treatment by time interaction with F (3,49) = 0.93, p = 0.4345. As illustrated in Fig. 5A , contrast sensitivity remained stable throughout the 24 h following saline treatment, but D-serine tended to increase contrast sensitivity from baseline at 4 h, an effect that did not reach significance however (F (1,49) = 3.42 , p = 0.4212 with Bonferroni correction). Visual acuity remained completely unchanged by saline or D-serine at all time points (Fig. 5B). 3.5. The rabbit NMDA model: enduring loss in contrast sensitivity function produced by a single IVT NMDA bolus Contrast sensitivity function captures a larger part of the visible world and is generally considered to provide a better measure of visual ability than high contrast grating acuity (Campbell & Robson, 1968; Jindra & Zemon, 1989; Marmor, 1986) and can even be used to predict letter acuity in humans (Watson & Ahumada, 2008) . By adapting the sweep VEP technology from humans to rabbits, we were able to measure visual acuity thresholds at various levels of contrast, and contrast sensitivity thresholds at various spatial frequencies, and then combine these data points to construct a CSF curve, which describes how contrast sensitivity varies as a function of spatial frequency (see Fig. 1 for a detailed illustration of this method). Points under the curve (large size, high contrast) are the regions in which the rabbit can detect visual signals, while points beyond the curve (small size, low contrast) are invisible to the normal rabbit. The present study used this technology to establish a stable model of retinal dysfunction by measuring CSF curves repeatedly before and after injection of NMDA into the eye to determine the extent and stability of any resulting deficit in vision.
A single IVT injection of 3.6 lmol NMDA causes inner retinal degeneration and has been used as a model of glaucoma (Dong et al., 2008) . Curves for both left and right eye were constructed from three contrast sensitivity thresholds (1.15, 1.45 and 1.75 cpd) and two visual acuity thresholds (20% and 80% contrast). Measurements were repeated across several days before the NMDA insult and confirmed that CSFs in different rabbits exhibit excellent test-retest repeatability across different frequencies. Specifically, the Coefficient of Variation (CV) was calculated to assess the consistency and precision of the assay, and animals with a score of 20% or higher at any point along the CSF curve for either of the two eyes were excluded from further studies, a criterion that typically affected one to three out of ten animals. Six of eight animals met this criterion for both eyes, all of which also displayed a VEP amplitude of at least 35 lV during acuity measurements at 80% contrast. NMDA was then administered into one eye, and PBS into the fellow eye, with assignment of NMDA to right versus left eye balanced. One week after the insult, CSF assessments were resumed and continued for many weeks to assess the extent and time course of any visual dysfunction. As illustrated in Fig. 6A , all six rabbits showed a dramatic loss in contrast sensitivity in the NMDA injected eye at week 2, as indicated by a large decrease in area under the CSF curve. This impairment did not deteriorate further but remained stable for more than 7 months. In contrast, CSF measures of the PBS injected eye were unchanged from baseline at week 2 and remained so thereafter (Fig. 6B) . The deficit in the NMDA injected eye was most pronounced at the lower and middle spatial frequencies, but visual acuity thresholds seemed unaffected at 7 months post NMDA (Fig. 6A) . The data were analyzed using MMRM ANOVAs with Bonferroni corrected F tests for individual comparisons. For CS at 1.15, overall the treatment by time interaction was not significant with F (1,20) = 2.02, p = 0.1702, but the NMDA effect (post vs. pre) was highly significant (F (1,20) = 13.57, p = 0.003 with Bonferroni correction). For CS at 1.45, the overall treatment by time interaction was not significant (F (1,20) = 1.51, p = 0.2330), but the NMDA post vs. pre difference was highly significant with F (1,20) = 14.99, p = 0.0018 with Bonferroni correction. For CS at 1.75, overall the treatment by time interaction was not significant (F (1,15) = 0.54, p = 0.4726), but the NMDA post vs. pre difference was very significant with F (1,15) = 8.75, p = 0.0196 with Bonferroni correction. For VA at 25% and 80% contrast, the overall treatment by time interactions were not significant and none of the post vs pre NMDA comparisons were significant. Data points with statistically significant NMDA induced decrements in contrast sensitivity compared to pre-NMDA baseline are marked with stars in Fig. 6A . All six rabbits were entered into a study that tested systemic D-serine (see Section 3.6). A subsequent cohort of 14 rabbits with baseline CSF curves equal to the first group was similarly treated with NMDA in one eye and vehicle in the fellow eye, yielding ten animals with significant reductions in contrast threshold that stabilized between two to four weeks and remained at that reduced level for as long as measured (at least 6 months), identical to the first cohort. All ten of them were entered in the systemic D-serine study and tested simultaneously with the 6 rabbits from the first cohort, as described below.
To verify the degree of retinal degeneration, the above group of 16 functionally impaired animals was examined by Optical Coherence Tomography (OCT) scanning. Both the retinal nerve fiber layer and the ganglion cell complex exhibited a significant reduction in thickness within the visual streak of the NMDA treated eyes compared to the vehicle treated control eyes in the same group of animals (data not shown), consistent with previous work (Dong et al., 2008) reporting that the same dose of intravitreal NMDA leads to a loss of about 40% of neurons in the retinal ganglion cell layer.
Systemic D-Serine improves contrast sensitivity function in rabbits with stable retinal injury
Rabbits with NMDA-induced visual dysfunction were treated with systemic D-serine. A total of 16 rabbits with stable CSF loss were pooled from the two NMDA cohorts described above. Complete CSF curves constructed from 5 points within the visible space (contrast thresholds at 1.15, 1.45 and 1.75 cpd, visual acuity thresholds at 25% and 80% contrast) were measured throughout the experiment, but only the NMDA-treated eyes were studied. D-serine was administered sc as a single acute injection of 600 mg/kg, the same dose previously found effective at restoring vision deficits in rats (see above). The study was conducted double masked, with half of the animals being treated daily with D-serine for 5 days, and the other half with saline (same volume) for 5 days, and crossover exposure took place two weeks later. On day 1 and day 5, full CSF curves were established before dosing and repeated 90 min after dosing. On day 3, only the 90 min post dose CSF curve was measured. Days 2 and 4 involved no testing. The key results are plotted in Fig. 7A that compares CSF curves taken during baseline on day 1 (BL) and 90 min post treatment on days 1, 3 and 5 (D1 90 min, D3 90 min, D5 90 min), as well as the original CSF curve for the same 16 eyes recorded before the NMDA insult many weeks earlier (pre NMDA). As can be seen, daily D-serine treatment clearly ameliorated the visual impairment and restored the entire CSF curve to pre NMDA levels. The NMDA-treated eyes of these same animals did not respond to vehicle administration and maintained a deficient CSF curve throughout the 5 days (Fig. 7B) . The enhancing effect of D-serine fluctuated in magnitude across spatial frequencies and time points but consistently remained above pretreatment level (BL), which was not the case when the same eyes were treated with vehicle during the crossover week.
The entire data set was analyzed using the MMRM approach with Bonferroni corrected F tests for individual comparisons. For CS at 1.15, overall the treatment by time interaction was not significant with F (4,135) = 1.90, p = 0.1132, but at time D5 90 min, the treatment effect (difference between D-serine and saline) was highly significant with F (1,135) = 10.58, p = 0.007 with Bonferroni correction. For D-serine, the time effect (D5 90 min vs D1 BL) was also highly significant with F (1,135) = 13.62, p = 0.0024 with Bonferroni correction. All other comparisons were not statistically significant. For CS at 1.45, overall the treatment by time interaction was not significant (F (4,135) = 1.88, p = 0.1178), but for D-serine the difference between D3 90 min vs D 1BL was marginally significant with F (1,135) = 7.39, p = 0.058 with Bonferroni correction. None of the other comparisons were statistically significant. For CS at 1.75, overall the treatment by time interaction was not significant (F (4,135) = 0.93, p = 0.4464). For D-serine, the difference between D5 90 min and D1 BL was highly significant with F (1,135) = 14.14, p = 0.0024 with Bonferroni correction. All other comparisons were not statistically significant. For VA at 25%, the overall treatment by time interaction was not significant (F (4,135) = 0.78, p = 0.5371. None of the post hoc comparisons were statistically significant. For VA at 80%, the overall treatment by time interaction was marginally significant (F (4,135) = 2.35, p = 0.0574. For D-serine, the difference between D3 90 min and D1 BL was significant with F (1,135) = 9.67, p = 0.0184 with Bonferroni correction. None of the other post hoc comparisons were statistically significant. Data points with statistically significant enhancement compared to pre D-serine (BL) are marked with stars in Fig. 7A .
Notably, all rabbits that first received D-serine showed a full return from the enhancement to baseline levels following the two-week washout period. Equally important, rabbits that first received vehicle maintained stable visual function throughout the testing period with no change in CSF two weeks post saline ''dosing". In sum, systemic D-serine acutely restored the contrast sensitivity function impaired by NMDA to pre-lesion levels.
A single IVT administration of D-serine improves contrast sensitivity in rabbits with stable retinal dysfunction
The discovery that systemic D-serine is capable of restoring CSF in an impaired visual system raised the question as to whether the enhancement was mediated by an effect in the retina, brain, or both? Therefore D-serine was administered by IVT injection in this final study that involved a new cohort of NMDA rabbits with a stable CSF decrement (n = 14). The study was initiated approximately 24 weeks after the NMDA insult. All sweep VEP recordings were conducted double masked, with half of the animals being treated with a single 50 ll intravitreal injection of 12 lmol of Dserine (10 mM final vitreal D-serine concentration), and the other half with an IVT injection of sucrose (same volume and molarity). Crossover exposure took place three weeks later. Similar to the first IVT study in intact rabbits, this final IVT study selectively focused on just three points on the CSF curve (contrast sensitivity at 1.15 cpd and 1.45 cpd, and visual acuity at 80% contrast) to allow for repeated sampling times after treatment (90 min and 4 h). For CS at 1.15 cpd, overall the treatment by time interaction was not significant (F (4,117) =1.40, p = 0.2387, but the treatment effect at 4 h (difference between D-serine and saline) was highly significant with F (1,117) = 11.73, p = 0.004 with Bonferroni correction. For CS at 1.45 cpd, the overall treatment by time interaction was not significant (F (4,117) = 0.49, p = 0.7461, and none of the individual comparisons were statistically significant. For VA 0.8, the overall treatment by time interaction was not significant (F (4,99) = 0.27, p = 0.8959, and none of the individual comparisons were statistically significant.
In sum, and as illustrated in Fig. 8 , D-serine produced a highly significant enhancement in visual performance at 4 h post treatment for CS at 1.15 cpd, but no significant facilitation for CS at 1.45 cpd and VA at 80%, even though both these measures responded to D-serine with a positive trend that peaked at 4 h that was less apparent following saline treatment. Vehicle administration had no effect on contrast sensitivity or visual acuity.
Discussion
Role of D-serine in neurological function and cortical LTP
D-Serine is considered to be an important physiological ligand at the NMDA receptor co-agonist site (Panatier et al., 2006) and has been shown to be more effective than glycine (Matsui et al., 1995; Stevens, Gustafson, Sullivan, Esguerra, & Miller, 2010) . The present findings provide support for the idea that co-agonist stimulation of the NMDA receptor via administration of exogenous Dserine has the potential to enhance visual performance and compensate for the loss of vision resulting from retinal insults. A role for D-serine in supporting healthy neurological function has previously been pointed out in reports of reduced serum levels of Dserine during aging and in patients with schizophrenia (Hashimoto et al., 2003) . Likewise, NMDA receptor blockade in healthy adults can induce cognitive impairments and schizophrenia-like psychotic symptoms (Krystal et al., 2003; Stone et al., 2008) , and oral supplementation with D-serine has been shown to significantly improve cognitive and psychotic symptoms in patients with schizophrenia (Kantrowitz et al., 2010; Tsai, Yang, Chung, Lange, & Coyle, 1998; Tsai et al., 1999) . Our results showing that administration of D-serine improved visual function that had been compromised by retinal insult highlight the potential benefit of D-serine therapy in visual disorders. It is interesting that D-serine was also found to enhance visual response properties of cortical neurons in an adult mouse amblyopia model and thereby restore ocular dominance plasticity (Yang et al., 2011) .
Consistent with previous reports (e.g., Kirkwood & Bear, 1994) we found that the adult visual cortex is capable of supporting LTP evoked in layer II/III by TBS of layer IV. LTP induction in this pathway is known to depend on NMDA receptor activation (Kirkwood & Bear, 1994) , but the potential influence of coagonist stimulation by exogenous D-serine was unclear. A prior study conducted in kitten visual cortex slices reported that Dserine alone did not enhance LTP and only produced a reversal of the suppressant effects of the NMDA receptor co-agonist site antagonist, 7-chlorokynurenic acid (Ito & Hicks, 2001 ). However, these authors used long trains of high frequency stimulation consisting of 1200 pulses, and they stimulated the white matter beneath layer VI which recruits very different cortical circuits than layer II/III. Cortical layer IV is the recipient of visual signals arriving by monosynaptic geniculo-cortical transmission, and TBS applied here is particularly effective at recruiting cortical circuits that support LTP (Heynen & Bear, 2001; Kirkwood & Bear, 1994) , an assertion supported by our current results. We specifically used a suboptimal version of TBS consisting of a total number of 60 pulses. Our objective was to produce modest levels of potentiation with room for pharmacological enhancement, an approach that was successful (see Fig. 2 ), and that confirms that the co-agonist binding site of synaptic NMDARs was not saturated, consistent with previous studies (Henneberger et al., 2010; Junjaud, Rouaud, Turpin, Mothet, & Billard, 2006; Yang et al., 2003) .
Relationship between LTP and vision
A very large body of experimental work has confirmed the tight connection between LTP and diverse instances of memory acquisition (for a review, see Lynch, Cox, & Gall, 2014 ). An early demonstration linking cortical LTP and perceptual learning comes from a study showing that olfactory learning is associated with the development of a persistent form of stimulus-specific synaptic potentiation in primary olfactory cortex (Roman, Staubli, & Lynch, 1987) . This does not mean that LTP and perceptual learning are one and the same. LTP is rapidly formed in response to a brief stimulus (seconds). Perceptual learning is slow and requires prolonged stimulus presentation (hours to days) as in the case of olfactory learning mentioned above, and as described in Cooke and Bear (2010) who demonstrated that repeated presentation of an oriented grating leads to a stimulus specific enhancement of visual evoked potentials in mouse primary visual cortex. They called it stimulus-response potentiation, or SRP, a naturalistic from of LTP. LTP and SRP share the same core mechanisms (NMDA dependent, stimulus specific and synapse specific), and they occlude each other. SRP may thus be considered a biomarker of LTP (Clapp et al., 2012; Cooke & Bear, 2012) , while the utility of LTP can be seen as a tool for rapidly evaluating the potential of pharmacological manipulations to enhance learning, including the acquisition of sensory information underlying perceptual learning. Improved performance on visual tasks may thus be possible through changes in neuroplasticity such as those observed during LTP experiments. Our present results obtained in vivo using systemic D-serine are consistent with this hypothesis. An essential aspect of these studies was the unique nature of the animal models we developed, and in particular the ability to record intra-cortical visually evoked responses in conscious rats and rabbits that were actively attending to and processing visual information presented on a monitor or projected directly onto the retina with a fundus camera.
Although the VEP does not represent actual vision but is a physiological mechanism, multiple comparative methodological studies show a consistent correlation between sweep VEP derived acuity estimates and logMAR acuity in human infants and adult patients (for a recent review see Ridder, Waite, & Melton, 2014) . Nevertheless, a pharmacological enhancement of VEPs may not translate into recovery of functional vision, and behavioral and clinical studies are needed to confirm D-serine's potential for treating impaired vision, which is the scope for future research. Pertinent to this are results from a recent primate psychophysical study in which daily oral D-serine produced a significant partial reversal of a blue-light induced decrement in contrast sensitivity function (unpublished data from Burke at al., Allergan). We found that systemic D-serine dose-dependently rescued the contrast sensitivity impairment in Long-Evans rats induced by blue-light treatment (Fig. 4) . This was not a neuroprotective effect, since improvement was seen with a single acute dose given many weeks after induction of the insult, when the visual deficit had stabilized. D-serine may produce this acute enhancement by temporarily boosting the function of the NMDA receptors in the retinal cells that remained unaffected by blue-light treatment. Endogenous D-serine in the retina contributes to NMDA-receptor mediated synaptic responses (Gustafson et al., 2007) , and lightevoked synaptic responses depend on D-serine ''tone" (Buldyrev et al., 2012; Kalbaugh et al., 2009; Stevens et al., 2010) . Alternatively, D-serine may have caused this effect by enhancing NMDA receptor function in areas of the brain that are part of the visual pathway. Enhancement of cortical plasticity has been reported with an identical dose of systemic D-serine in mice following monocular deprivation (Yang et al., 2011) . In sum, systemic Dserine administration dose-dependently ameliorated a decrement in CSF induced by exposure of the retina to blue light.
Effects of exogenous
Restorative effects of systemic D-serine on impaired vision in rabbits
Adapting the sweep VEP technology to conscious rabbits allowed us to extend the evaluation of systemic D-serine administration to a model of inner retinal degeneration. By employing the methodology outlined in Fig. 1 , which combines fundus stimulation with intra-cortical VEP recording, we were able to measure complete CSF curves and establish the limits of vision function in rabbits before and after being treated with IVT NMDA to produce inner retinal degeneration. Intravitreal NMDA had been used previously as a rabbit model of glaucoma (Dong et al., 2008) , and we were able to adapt this technique successfully to create rabbits with stable impairments in contrast sensitivity. Capturing drug-induced changes in area under the CSF curve allowed us to monitor the time course and quantify the extent to which NMDA-induced retinal degeneration impairs, and D-serine restores vision across specific spatial frequency ranges. IVT NMDA injection caused a significant and persistent leftward shift of the CSF curve across all but the two highest spatial frequencies (Fig. 6A) , a deficit that was acutely rescued by daily systemic D-serine injections (see Fig. 7A ). The return towards pre-NMDA-treatment levels produced by D-serine was apparent on day 1 and complete by the end of day 5 (Fig. 7A  insert) , while the deficit remained unchanged in response to vehicle administration (Fig. 7B) . These results confirm and extend our original observation in rats by showing that systemic D-serine is capable of restoring vision loss across a broad range of spatial frequencies. D-Serine may have caused this effect by acting on NMDA receptors in the brain that are part of the visual pathway projecting from the eye to the cortex. Alternatively, systemic D-serine has the potential to access the eye through the choroid and enhance the operation of retinal NMDA receptors in cells that survive NMDA treatment. One way to address these two possibilities was to examine if D-serine administered locally into the eye (IVT) is effective at repairing vision loss in NMDA-treated rabbits.
4.3.3. Differential facilitatory effects of IVT D-serine on visual performance in intact vs vision impaired rabbits Intravitreal D-serine, which was tested first in normal rabbits with intact vision, was found to produce a slight improvement in contrast sensitivity but not high-contrast visual acuity (Fig. 5) . This trend towards improvement in contrast sensitivity did not reach statistical significance, however, presumably due to the variability in this small sample size (n = 8). This suggests that supplementing D-serine in a normal system is not very effective at providing visual enhancement, implying that there is little if any room for improvement in the intact visual system.
In NMDA-treated rabbits with impaired vision, IVT D-serine produced a significant enhancement in visual performance (contrast sensitivity at 1.15 cpd) at 4 h post treatment, but had no impact at 90 min or 24 and 48 h (Fig. 8) . It is noteworthy that the timedependency of this enhancement was identical to the trend observed in intact rabbits given IVT D-serine (Fig. 5) where contrast sensitivity clearly peaked at 4 h post D-serine (p = 0.0702 with F (1,49) = 3.42), an effect of marginal significance that was lost after correcting for multiple time point comparisons.
In summary, elevation of retinal D-serine levels are sufficient to provide a rescue of visual function. This indicates that D-serine can improve visual function at the level of the retina, perhaps by facilitating the function of unaffected RGCs, so that they can compensate for the reduced output of the damaged retina. A retinal site of action however does not rule out additional beneficial effects of systemically administered D-serine operating on the visual pathways in the brain by potentially increasing NMDA receptor function in the lateral geniculate or visual cortex and thereby enhancing forms of synaptic plasticity such as LTP.
Conclusion
The NMDA subtype of glutamate receptors and its co-agonist D-serine play pivotal roles in neural communication and plasticity in the brain including the visual system. Retinal degeneration is associated with glutamate hypofunction, a condition where Dserine is predicted to rescue visual function by boosting NMDA receptor activation. To test this idea, we developed unique sweep VEP methods to measure visual function in conscious rats and rabbits with long-term, stable visual deficits resulting from retinal injury. We have provided preliminary evidence that administration of D-serine locally into the eye or systemically rapidly improved contrast sensitivity function that had been impaired by either an outer or inner retinal insult. This was not a neuroprotective effect but an enhancement phenomenon, obtained with a single dose given when the retinal lesion had stabilized. The restorative action on vision by exogenous Dserine was acute, suggesting that D-serine exerts its beneficial effect by temporarily increasing glutamatergic synaptic transmission or perhaps by strengthening a form of synaptic plasticity such as SRP (Cooke & Bear, 2010 . If confirmed by additional studies, the present experiments suggest that D-serine may warrant testing as a therapy for impaired visual function in humans and that patients would require daily dosage. In analogy, clinical studies demonstrating beneficial effects of D-serine for treatment of schizophrenia typically involve daily dosing for several weeks (Kantrowitz et al., 2010 (Kantrowitz et al., , 2015 .
